FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:997-999 October 2, 1997 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Cystic fibrosis is one of the most common inheritable diseases among white people, and without treatment most patients with this disease die in infancy or early childhood. The steadily increasing survival of patients with cystic fibrosis in countries in which specialized care is available indicates that treatment is effective.¹ Detecting the disease by screening, which might allow treatment to be initiated before irreversible damage has occurred, could further improve the outcome. In 1983 the Task Force on Neonatal Screening took a strong position against implementing neonatal screening for cystic fibrosis until more was known about the benefits and risks of . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Baussano, I., Tardivo, I., Bellezza-Fontana, R., Forneris, M. P., Lezo, A., Anfossi, L., Castello, M., Aleksandar, V., Bignamini, E. (2006). Neonatal Screening for Cystic Fibrosis Does Not Affect Time to First Infection With Pseudomonas aeruginosa. Pediatrics 118: 888-895 [Abstract] [Full Text]  
• Saenz, A., Leturcq, F., Cobo, A. M., Poza, J. J., Ferrer, X., Otaegui, D., Camano, P., Urtasun, M., Vilchez, J., Gutierrez-Rivas, E., Emparanza, J., Merlini, L., Paisan, C., Goicoechea, M., Blazquez, L., Eymard, B., Lochmuller, H., Walter, M., Bonnemann, C., Figarella-Branger, D., Kaplan, J. C., Urtizberea, J. A., Marti-Masso, J. F., de Munain, A. L. (2005). LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain 128: 732-742 [Abstract] [Full Text]  
• Sawyer, S. M., Glazner, J. A. (2004). What Follows Newborn Screening? An Evaluation of a Residential Education Program for Parents of Infants With Newly Diagnosed Cystic Fibrosis. Pediatrics 114: 411-416 [Abstract] [Full Text]  
• Sarles, J., Barthellemy, S., Férec, C., Iovanna, J., Roussey, M., Farriaux, J.-P., Toutain, A., Berthelot, J., Maurin, N., Codet, J.-P., Berthézène, P., Dagorn, J.-C. (1999). Blood concentrations of pancreatitis associated protein in neonates: relevance to neonatal screening for cystic fibrosis. Arch. Dis. Child. Fetal Neonatal Ed. 80: 118F-122 [Abstract] [Full Text]  
• Dodge, J A, Lane, B., Harris, R., Harris, H., Pollitt, R. (1998). Neonatal screening for cystic fibrosis. BMJ 317: 411-411 [Full Text]  
• Wald, N. J, Morris, J. K (1998). Neonatal screening for cystic fibrosis. BMJ 316: 404-405 [Full Text]